Skip to main content

To pressure Hamas, PA now sticking it to the sick

The health of thousands of sick Palestinians in Gaza is in jeopardy as the Palestinian Authority cuts off medical supplies.
A Palestinian woman tends to her mother undergoing kidney dialysis at al-Shifa hospital in Gaza City September 12, 2013. Cairo closed the Rafah crossing completely on Wednesday after assailants crashed two explosive-laden cars into a security building adjacent to the border zone, killing six Egyptian soldiers. Ashraf al-Qidra, spokesman for the Hamas-run Gaza Health Ministry, said 1,000 patients a month required medical care in Egypt and in other countries. Rafah's closure, he said, would also affect the im

GAZA CITY, Gaza Strip — A massive health crisis is looming in the Gaza Strip, as the Palestinian Authority (PA) in the West Bank has halted shipments of essential medicine, baby formula for sick children and medical supplies.

The Ministry of Health in the national consensus government in Ramallah notified its counterpart in Gaza that it was stopping the shipments May 8. The medication and medical equipment/supply shortage has reached a critical stage, as more than 170 drugs out of the 500 essential ones have run out.

The decision to ban medical supplies to Gaza is part of the PA's most recent measures to tighten the noose on Hamas, which has controlled the Gaza Strip since 2007 and is at odds with PA President Mahmoud Abbas and his Fatah party. The PA administers the West Bank. Other already-imposed measures have affected employees' salaries and cut off Gaza's power and water supplies.

Munir al-Barsh, general director of the Health Ministry’s pharmaceutical department in the Gaza Strip, told Al-Monitor, “The consensus government … is responsible for supplying medication and medical and health supplies worth $40 million yearly to the Gaza Strip. The supplies are distributed to sick people for free, and those [people] benefit from the Palestinian medical insurance and receive treatment in hospitals and clinics affiliated with the ministry.”

He said the West Bank ministry is using "the pretext that [the supplies] aren’t available in their warehouses in Ramallah."

"But we contacted companies that supply medication to the Health Ministry, and they told us that it is possible to supply Gaza. This reveals the intention to stir a health crisis in the Gaza Strip," he noted.

Already, about 31% of the essential medicines are completely depleted from the Gaza ministry warehouses, Barsh said, and another 30% might run out within weeks, "thus foreshadowing a possible humanitarian crisis in the Gaza Strip.”

He noted that the Ministry of Health in Ramallah is required to supply the essential medications, as determined by specialized committees and recommendations from the World Health Organization (WHO). Much of the medication and supplies being held up by Ramallah are designated for Gaza by donor countries and WHO.

The drug supplies that have been exhausted are needed for kidney transplants and the treatment of cancer and blood disorders such as thalassemia and hemophilia. Many supplies used in emergency rooms and surgery have also run out.

More than 90% of cancer patients have not received treatment since May 8, Barsh said. The lack of cancer medication will force patients to seek treatment abroad, meaning they will have to get through Israeli crossings to reach Jordanian, Egyptian or West Bank hospitals.

“The Gaza Health Ministry notified international organizations on May 18 about the dangers of halting treatment in Gaza," he said.

Even if the Gaza Health Ministry had money in its treasury to pay for the supplies — which it doesn't, Barsh said — such purchases require three to five months to complete and involve new tenders and mediating foreign companies.

Among those suffering are children with galactosemia. They will soon be deprived of treatment after Galactomin 19 formula runs out, thus threatening their lives and potentially leading to disability. Galactosemia is an inherited disease resulting from the body’s inadequate ability to metabolize the sugar galactose.

Barsh added that formula is not available in local markets in Gaza, and the price keeps rising and has reached $130 per carton compared with $70 before supplies were stopped. A family forced to pay for the medicine would need about $1,000 a month to treat one sick child. Sick children drink Galactomin from birth, as it is their main source of nutrition and medication to survive and ensure normal growth.

Muhammad Suleiman, 5, suffers from galactosemia. He sleeps most of the time, as he feels constantly bloated. He has been off Galactomin since early May. His mother, Samah, told Al-Monitor, “In the absence of Galactomin, my boy is in danger and his suffering is worsening. He must follow a strict galactose-free diet.”

She added that she cannot afford to buy the medication herself.

Raed Sultan told Al-Monitor he underwent a kidney transplant three months ago and has not received his medication. It is unavailable in the state hospitals, and he does not have enough money to buy it from pharmacies in the Gaza Strip.

Since the decision to halt medication and medical supplies to state hospitals in the Gaza Strip was issued, Hana Samara, who is only 32 and suffers from breast cancer, has found that her medication is unavailable in al-Rantisi state hospital in Gaza City and other hospitals, or even at pharmacies or private hospitals. Her health condition is worsening and her life is at risk.

She told Al-Monitor she has been receiving treatment and hormonal injections to prevent carcinogenic cells from multiplying and spreading in her body. Once the medication runs out, she will bleed and suffer complications. 

Samara is but one of thousands of patients in the Gaza Strip who rely on free treatment from state clinics and hospitals as part of their medical insurance, and whose well-being is jeopardized.

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Free

The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.

Free

What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing
Expert

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial

We also offer team plans. Please send an email to pro.support@al-monitor.com and we'll onboard your team.

What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial